Iksuda Therapeutics

OverviewSuggest Edit

Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. It provides PermaLink, conjugation chemistry for improved ADC stability, ultra-potent toxins for tumour killing, as well as antibodies targeted towards antigens associated with solid tumours.
TypePrivate
Founded2007
HQNewcastle upon Tyne, GB
Websiteiksuda.com

Locations

Iksuda Therapeutics is headquartered in
Newcastle upon Tyne, United Kingdom

Location Map

Latest Updates

Employees (est.) (Jan 2022)19(+6%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Iksuda Therapeutics

David Simpson

David Simpson

Chief Executive Officer & Director
Robert Lutz

Robert Lutz

Chief Science Officer
Ian Evetts

Ian Evetts

Chief Business Officer
Sam Williams

Sam Williams

Non-Executive Chairman
Jenny Thirlway

Jenny Thirlway

Senior Director, Development Program Team Leader
Michael Owen

Michael Owen

Non-Executive Director
Show more

Iksuda Therapeutics Office Locations

Iksuda Therapeutics has offices in Newcastle upon Tyne and Newton
Newcastle upon Tyne, GB (HQ)
Draymans Way Newcastle Helix
Newton, MA, US
Riverside Center, 275 Grove St suite 2 - 400, Auburndale
Show all (2)

Iksuda Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2007

Iksuda Therapeutics total Funding

$47 m

Iksuda Therapeutics latest funding size

$47 m

Time since last funding

8 months ago

Iksuda Therapeutics investors

Iksuda Therapeutics's latest funding round in June 2021 was reported to be $47 m. In total, Iksuda Therapeutics has raised $47 m
Show all financial metrics

Iksuda Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

Iksuda Therapeutics Online and Social Media Presence

Embed Graph

Iksuda Therapeutics Frequently Asked Questions

  • When was Iksuda Therapeutics founded?

    Iksuda Therapeutics was founded in 2007.

  • Who are Iksuda Therapeutics key executives?

    Iksuda Therapeutics's key executives are David Simpson, Robert Lutz and Ian Evetts.

  • How many employees does Iksuda Therapeutics have?

    Iksuda Therapeutics has 19 employees.

  • Who are Iksuda Therapeutics competitors?

    Competitors of Iksuda Therapeutics include Janux Therapeutics, Day One Biopharmaceuticals and Bexion Pharmaceuticals.

  • Where is Iksuda Therapeutics headquarters?

    Iksuda Therapeutics headquarters is located at Draymans Way Newcastle Helix, Newcastle upon Tyne.

  • Where are Iksuda Therapeutics offices?

    Iksuda Therapeutics has offices in Newcastle upon Tyne and Newton.

  • How many offices does Iksuda Therapeutics have?

    Iksuda Therapeutics has 2 offices.